The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type IIIL-1 receptor to inhibit IL-1 action

被引:150
|
作者
Smith, DE
Hanna, R
Friend, D
Moore, H
Chen, H
Farese, AM
MacVittie, TJ
Virca, GD
Sims, JE
机构
[1] Amgen Corp, Seattle, WA 98101 USA
[2] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
关键词
D O I
10.1016/S1074-7613(02)00514-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulation of the activity of the proinflammatory cytokine IL-1 is complex, involving transcriptional and translational control, precursor processing, a receptor antagonist (IL-1ra), and a decoy receptor. Here we report that the soluble form of the IL-1 receptor accessory protein (AcP) increases the affinity of binding of human IL-1alpha and IL-1beta to the soluble human type 11 IL-1 receptor by approximately 100-fold, while leaving unaltered the low binding affinity of IL-1ra. Soluble AcP is present in normal human serum at an average concentration greater than 300 ng/ml. These findings suggest that the soluble form of IL-1 R AcP contributes to the antagonism of IL-1 action by the type 11 decoy receptor, adding another layer of complexity to the regulation of IL-1 action.
引用
收藏
页码:87 / 96
页数:10
相关论文
共 50 条
  • [1] IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein
    Jensen, LE
    Muzio, M
    Mantovani, A
    Whitehead, AS
    JOURNAL OF IMMUNOLOGY, 2000, 164 (10): : 5277 - 5286
  • [2] IL-1β scavenging by the type IIIL-1 decoy receptor in human neutrophils
    Bourke, E
    Cassetti, A
    Villa, A
    Fadlon, E
    Colotta, F
    Mantovani, A
    JOURNAL OF IMMUNOLOGY, 2003, 170 (12): : 5999 - 6005
  • [3] Soluble type IIIL-1 decoy receptor: Reversal of autocrine and paracrine effects of IL-1 in human arthritis.
    Amin, AR
    Attur, MG
    Dave, MN
    Cipolletta, C
    Patel, IR
    Abramson, SB
    Kang, P
    Goldring, MB
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S353 - S353
  • [4] Analysis of interleukin (IL)-Iβ IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders
    Libra, M
    Mangano, K
    Anzaldi, M
    Quattrocchi, C
    Donia, M
    Di Marco, R
    Signorelli, S
    Scalia, G
    Zignego, AL
    De Re, V
    Mazzarino, MC
    Nicoletti, F
    ONCOLOGY REPORTS, 2006, 15 (05) : 1305 - 1308
  • [5] IL-1 receptor accessory protein is an essential component of the IL-1 receptor
    Cullinan, EB
    Kwee, L
    Nunes, P
    Shuster, DJ
    Ju, G
    McIntyre, KW
    Chizzonite, RA
    Labow, MA
    JOURNAL OF IMMUNOLOGY, 1998, 161 (10): : 5614 - 5620
  • [6] The IL-1 system in HIV infection: Peripheral concentrations of IL-1 beta, IL-1 receptor antagonist and soluble IL-1 receptor type II
    Kreuzer, KA
    Dayer, JM
    Rockstroh, JK
    Sauerbruch, T
    Spengler, U
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01): : 54 - 58
  • [7] IL-1β, IL-1 receptor antagonist and soluble type II IL-1 receptor in synovial fluid of patients with temporomandibular disorders
    Tominaga, K
    Habu, M
    Sukedai, M
    Hirota, Y
    Takahashi, T
    Fukuda, J
    ARCHIVES OF ORAL BIOLOGY, 2004, 49 (06) : 493 - 499
  • [8] The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33
    Palmer, Gaby
    Lipsky, Brian P.
    Smithgall, Molly D.
    Meininger, David
    Siu, Sophia
    Talabot-Ayer, Dominique
    Gabay, Cem
    Smith, Dirk E.
    CYTOKINE, 2008, 42 (03) : 358 - 364
  • [9] Effects of IL-1 receptor accessory protein on IL-1 binding
    Wesche, H
    Resch, K
    Martin, MU
    FEBS LETTERS, 1998, 429 (03) : 303 - 306
  • [10] Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1β activity but not binding:: Regulation of IL-1 responses is via type I receptor, not the accessory protein
    Yoon, DY
    Dinarello, CA
    JOURNAL OF IMMUNOLOGY, 1998, 160 (07): : 3170 - 3179